IL112844A - In-vitro angiogenesis assays - Google Patents

In-vitro angiogenesis assays

Info

Publication number
IL112844A
IL112844A IL11284495A IL11284495A IL112844A IL 112844 A IL112844 A IL 112844A IL 11284495 A IL11284495 A IL 11284495A IL 11284495 A IL11284495 A IL 11284495A IL 112844 A IL112844 A IL 112844A
Authority
IL
Israel
Prior art keywords
fragment
angiogenesis
growth
vascular tissue
nutrients
Prior art date
Application number
IL11284495A
Other languages
English (en)
Other versions
IL112844A0 (en
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Australian filed Critical Univ Australian
Publication of IL112844A0 publication Critical patent/IL112844A0/xx
Publication of IL112844A publication Critical patent/IL112844A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL11284495A 1994-03-04 1995-03-02 In-vitro angiogenesis assays IL112844A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM4252A AUPM425294A0 (en) 1994-03-04 1994-03-04 In-vitro angiogenesis assay

Publications (2)

Publication Number Publication Date
IL112844A0 IL112844A0 (en) 1995-06-29
IL112844A true IL112844A (en) 1998-12-06

Family

ID=3778868

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11284495A IL112844A (en) 1994-03-04 1995-03-02 In-vitro angiogenesis assays

Country Status (9)

Country Link
US (1) US5976782A (fr)
EP (1) EP0804727A4 (fr)
JP (1) JPH09509829A (fr)
AU (1) AUPM425294A0 (fr)
CA (1) CA2184705A1 (fr)
IL (1) IL112844A (fr)
TW (1) TW394844B (fr)
WO (1) WO1995023968A1 (fr)
ZA (1) ZA951778B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225118B1 (en) 1997-10-01 2001-05-01 Biocure Limited Multicellular in vitro assay of angiogenesis
GB2331763B (en) * 1997-10-01 2000-03-22 Biocure Ltd A Multicellular in vitro assay of angiogenesis
FR2798674B1 (fr) * 1999-09-21 2004-01-30 Mahmood Salman Al Procede d'identification de nouveaux genes impliques dans la regulation de l'angiogenese, etude de ces genes et leur utilisation a des fins therapeutiques
US6329348B1 (en) 1999-11-08 2001-12-11 Cornell Research Foundation, Inc. Method of inducing angiogenesis
US6893812B2 (en) * 2000-05-30 2005-05-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Three-dimensional ex vivo angiogenesis system
WO2002020729A2 (fr) * 2000-09-06 2002-03-14 UNIVERSITé LAVAL Modele d'angiogenese humaine in vitro
US6436629B1 (en) * 2000-10-27 2002-08-20 The Regents Of The University Of California Modulating angiogenesis
US7407773B2 (en) * 2000-11-03 2008-08-05 Procognia, Ltd. Method for characterizing a carbohydrate polymer
US20020146679A1 (en) * 2001-01-29 2002-10-10 Karathanasis Sotirios K. Method for creating endothelial cell dysfunction in cell culture
ES2185493B1 (es) * 2001-07-03 2004-06-16 Madrid Genetics, S.L. Metodo para evaluar in vitro en condiciones fisiologicas o patologicas relevantes la actividad biologica de compuestos a gran escala.
NZ530985A (en) * 2001-08-29 2006-03-31 Genentech Inc Bv8 nucleic acids and polypeptides with mitogenic activity
NZ554534A (en) * 2001-09-27 2008-10-31 Bionomics Ltd DNA sequences for human angiogenesis genes
AU2002362020A1 (en) * 2001-11-26 2003-06-10 Exelixis, Inc. CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE
JP2005536189A (ja) * 2002-04-12 2005-12-02 セルジーン・コーポレーション 血管新生のモジュレーターの同定方法、それにより見出された化合物および該化合物を使用する治療方法
AU2003248731A1 (en) 2002-06-26 2004-01-19 Children's Hospital Medical Center In vivo angiogenesis assay
FR2845691B1 (fr) * 2002-10-10 2004-12-10 Centre Nat Rech Scient Nouvelles cellules endotheliales, anticorps diriges contre ces cellules et leur utilisation, notamment pour le criblage de substances inhibant l'angiogenese
SE526959C2 (sv) * 2003-10-02 2005-11-29 Tikomed Ab Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall
US20100266558A1 (en) * 2007-12-18 2010-10-21 Dov Zipori Method and assay for glycosylation pattern detection related to cell state of stem cells
EP2981273B1 (fr) * 2013-04-02 2020-09-16 University of Florida Research Foundation, Inc. Compositions et procédés permettant d'induire et de moduler l'angiogenèse et procédés et dosages permettant d'identifier des modulateurs de l'angiogenèse
US11884647B2 (en) 2019-10-18 2024-01-30 The Regents Of The University Of California Compounds and methods for targeting pathogenic blood vessels
EP4045908A1 (fr) * 2019-10-18 2022-08-24 The Regents Of The University Of California Modèle d'angiogenèse tumorale ex vivo
CN111518746A (zh) * 2020-05-18 2020-08-11 南通大学 一种角膜微口袋手术实验中微丸的制备方法及应用

Also Published As

Publication number Publication date
IL112844A0 (en) 1995-06-29
JPH09509829A (ja) 1997-10-07
US5976782A (en) 1999-11-02
WO1995023968A1 (fr) 1995-09-08
ZA951778B (en) 1996-01-25
CA2184705A1 (fr) 1995-09-08
EP0804727A1 (fr) 1997-11-05
AUPM425294A0 (en) 1994-03-31
TW394844B (en) 2000-06-21
EP0804727A4 (fr) 1998-08-05

Similar Documents

Publication Publication Date Title
US5976782A (en) In-vitro angiogenesis assay
Fletcher et al. Lineage-restricted clonality in biphasic solid tumors.
Oren-Benaroya et al. The sperm chemoattractant secreted from human cumulus cells is progesterone
Khan et al. Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis
Sutherland et al. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix
Gleeson et al. Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through α5β1 integrin via mitogen-activated protein kinase pathway
US5382514A (en) In vivo angiogenesis assay
Ahmed et al. Localization of the angiotensin II and its receptor subtype expression in human endometrium and identification of a novel high-affinity angiotensin II binding site.
US11124756B2 (en) Method and apparatus for isolating invasive and metastatic cells for evaluating therapeutics and prediction of metastatic capacity
Leach et al. High throughput, cell type-specific analysis of key proteins in human endometrial biopsies of women from fertile and infertile couples
Matsumoto et al. Regulation of proliferation, motility, and contractility of human endometrial stromal cells by platelet-derived growth factor
Taguchi et al. Endothelial nitric oxide synthase is differently expressed in human endometrial vessels during the menstrual cycle
Abberton et al. Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles
Manconi et al. Culturing endothelial cells of microvascular origin
Akoum et al. Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis
Pederson et al. Evidence of a correlation of estrogen receptor level and avian osteoclast estrogen responsiveness
Shiose et al. Fibrinogen stimulates in vitro angiogenesis by choroidal endothelial cells via autocrine VEGF
Marin et al. Distribution of c-myc oncoprotein in healthy and atherosclerotic human carotid arteries
McClellan et al. Estrogen receptors, progestin receptors and DNA synthesis in the macaque endometrium during the luteal-follicular transition
AU679340B2 (en) (In vitro) angiogenesis assay
Sanyal et al. Endothelial cells lining transjugular intrahepatic portasystemic shunts originate in hepatic sinusoids: implications for pseudointimal hyperplasia
Trombi et al. Good manufacturing practice–grade fibrin gel is useful as a scaffold for human mesenchymal stromal cells and supports in vitro osteogenic differentiation
JP2008534022A (ja) 腫瘍組織、とりわけ乳癌から初代培養腫瘍細胞を得るための方法、初代培養腫瘍細胞およびそれらの使用
Kawagoe et al. Immunohistochemical demonstration of epidermal growth factor (EGF) receptors in normal human placental villi
Sundberg et al. Two different PDGF β-receptor cohorts in human pericytes mediate distinct biological endpoints

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees